Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ornipressin is an agonist of the vasopressin V1A receptor and a synthetic peptide derivative of argipressin (Item No. 24154) containing an arginine-to-ornithine substitution at position eight.1 It selectively induces reporter gene expression in HEK293 cells expressing vasopressin V1A and V2 receptors (EC50s = 0.69 and 0.45 nM, respectively, for the human receptors) over cells expressing vasopressin V1B receptors.2 It is selective for vasopressin V1A and V2 receptors over the vasopressin V1B receptor and oxytocin receptor (EC50s = 7.5 and 71 nM, respectively, for the human receptors). Ornipressin increases arterial blood pressure in rats when administered at a dose of 0.1 nmol/kg.
WARNING This product is not for human or veterinary use.
1. The pharmacology of ornipressin (POR-
2. New, potent, selective, and short-